Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy.
Sugihara K, Wakiya R, Shimada H, Kameda T, Nakashima S, Kato M, Miyagi T, Mizusaki M, Mino R, Nomura Y, Inoo M, Kadowaki N, Dobashi H.
Sugihara K, et al. Among authors: kadowaki n.
Intern Med. 2022 Jul 1;61(13):1953-1958. doi: 10.2169/internalmedicine.9223-21. Epub 2022 Apr 23.
Intern Med. 2022.
PMID: 35466168
Free PMC article.